Dermatology Year-End Billing Challenges: Why Revenue Drops and How Outsourcing Protects Practices

Image
Top Year-End Billing Pain Points Dermatology practices face some of the most complicated coding and reimbursement issues at the end of the year. Seasonal appointment spikes put additional pressure on billing teams struggling with: Declining reimbursements for common procedures such as biopsies, lesion excisions, cryotherapy, and Mohs services Payer-to-payer coding variability, especially on pathology-linked services Bundling disputes where multiple procedures performed in the same session are denied due to improper modifier usage Cosmetic vs. medical necessity confusion, leading to denials when documentation doesn’t clearly justify why a lesion needed removal Increased scrutiny on skin cancer—related services due to rising utilization These persistent challenges often leave dermatologists with more unpaid claims, lost revenue, and rising patient AR at year-end. What Practices Are Doing Right Now To reduce claim rejections before the year ends, most dermatology practices are: Re-trainin...

COVID Pathology, Now on the Down Turn… Who will Clean up Your AR?

 


Exponential Growth of Pathology Services during COVID-19 

COVID-19 is caused by severe acute respiratory syndrome corona virus-2 (SARS CoV-2), a highly contagious single-stranded RNA virus genetically related to SARS CoV. The lungs are the main organs affected leading to pneumonia and respiratory failure in severe cases that may need mechanical ventilation. Pathologically, the lungs show either mild congestion and alveolar exudation or acute respiratory distress syndrome (ARDS) with hyaline membrane or histopathology of acute fibrinous organizing pneumonia (AFOP) that parallels disease severity. The treatment for COVID-19 was principally symptomatic and prevention by proper use of personal protective equipment and other measures is crucial to limit the spread. Digital pathology was also introduced and the COVID-19 pandemic accelerated its adoption as there is the need to deal with higher (as much as 250 percent increase) case volume. During the COVID-19 pandemic, pathology billing witnessed high denied claims and staggering account receivables (AR). Our AR Cleanup & Insurance Follow-up Specialist Clean up your AR services to reduce medical practice costs & recover overdue payments from insurance carriers.

Pathology Billing During Pandemic

Even though the need for pathology services has increased exponentially, patient and insurance collection hasn’t increased to that extent. Billing and collecting for pathology and laboratory services is ‘tough’ and things got tougher during a pandemic. During the COVID-19 pandemic, most of the claims were denied by insurance carriers due to the absence of correct procedure codes, non-payable diagnosis codes, and incomplete documentation failing to prove medical necessity. Pathologists struggled to collect insurance reimbursement both as in-network and as out-of-network for various payers. 


To get more information about COVID Pathology click here: https://bit.ly/3I9uREg. Get in touch with us at: info@medicalbillersandcoders.com/ 888-357-3226. 

Comments

Popular posts from this blog

How to Reduce Days in A/R with Smart Denial Management Strategies

How Outsourced Medical Billing Can Improve Your Practice’s Profitability

Understanding the Differences Between Claim Denials and Rejections in Medical Billing